-
Signature
-
/s/ Jonathan Allan, Attorney-in-Fact
-
Issuer symbol
-
STOK
-
Transactions as of
-
10 Mar 2026
-
Net transactions value
-
-$174,214
-
Form type
-
4
-
Filing time
-
12 Mar 2026, 16:57:26 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| TZIANABOS ARTHUR |
Interim Executive Chair, Director |
C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD |
/s/ Jonathan Allan, Attorney-in-Fact |
12 Mar 2026 |
0001586226 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
STOK |
Common Stock |
Options Exercise |
|
+3,955 |
+12% |
$8.33* |
35,694 |
10 Mar 2026 |
Direct |
|
| transaction |
STOK |
Common Stock |
Sale |
$174,214 |
-4,355 |
-12% |
$40.00 |
31,339 |
10 Mar 2026 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
STOK |
Stock Option (Right to Buy) |
Options Exercise |
|
-3,955 |
-3.2% |
$0.000000* |
118,696 |
10 Mar 2026 |
Common Stock |
3,955 |
$8.33 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: